KALA BIO, Inc.

Ownership Transactions Reported by 18 Insiders

Symbol
KALA on Nasdaq
Industry
Pharmaceutical Preparations
Location
1167 Massachusetts Avenue, Arlington, MA

Insiders trading volume in the past year

KALA BIO, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Rajeev M. Shah Director $73.6M Jun 17, 2021
Ra Capital Management, L.P. 10%+ Owner $47.4M May 26, 2022
Gregory Grunberg Director $36.7M Jun 17, 2021
Hongming Chen Chief Scientific Officer $1.38M Oct 26, 2021
Baker Bros. Advisors Lp Former 10% owner $588K +$943K Sep 30, 2025
Eric Trachtenberg Chief Legal Officer, Chief Compliance Officer and Secretary $459K Jan 4, 2024
Robert Bradley Paull Director $286K Jun 16, 2022
Mark T. Iwicki Director $212K -$138K -39.4% Oct 23, 2025
Mark S. Blumenkranz Director $87.5K Jun 11, 2024
Darius Kharabi Chief Business Officer $85.6K -$36.2K -29.7% Oct 22, 2025
Romulus K. Brazzell Head of Research and Development and Chief Medical Officer $73.7K -$34.8K -32.1% Oct 22, 2025
Todd Bazemore Director $73.7K -$44.2K -37.5% Oct 22, 2025
Mary Reumuth Chief Financial Officer $59.3K -$38.2K -39.2% Oct 22, 2025
Andrew I. Koven Director $59.1K Jun 15, 2025
Howard B. Rosen Director $57.4K Jun 15, 2025
Gregory D. Perry Director $46.4K Jun 15, 2025
C. Daniel Myers Director $36.1K Jun 15, 2025
Marjan Farid Director $35.6K Jun 15, 2025

Recent Insider Transactions by Companies or Individuals for KALA BIO, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.